Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBPF25P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCAND2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS4X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VDAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPAGT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APEX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF318 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WAC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on